Application note: Raman spectroscopy to study the distribution of compounds in a pharmaceutical drug product
Posted: 18 July 2017 | HORIBA Scientific | No comments yet
In this application note, HORIBA discuss using raman spectroscopy to study the distribution of compounds in pharmaceutical drug products…
Resulting from the combination of Raman spectroscopy and optical microscopy, Raman hyperspectral imaging has proven to be an indispensable tool in the pharmaceutical field, especially to study the distribution of active(s) and excipients in a pharmaceutical drug product.
Introduction
In the pharmaceutical environment, and especially in the research and development field, the quality of the medicine is a critical step as it faces challenges with increased demand from the regulatory affairs to improve the quality of a pharmaceutical drug product. In order to ensure its proper effect on the patient health, a product has to be manufactured with exacting quality.
This application note is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
Related topics
Drug Development, Drug Manufacturing, Excipients, QA/QC, Raman Spectroscopy, Regulation & Legislation
